AS reports consultancy fees from Novartis, AbbVie, Vertex and Orion Pharma and speaker fees from Teva UK and Novartis
Weight loss injections are a popular treatment option because it delivers great results for so many people
Ozempic, though it has the same chemical composition as Wegovy, is approved for the treatment of diabetes
In contrast, patients treated with Ozempic often experience more substantial weight loss, averaging approximately 1015% or more of their initial body weight over the same time frame, especially at higher dosages
These letters addressed concerns including misleading advertising, quality control issues, and compliance failures
A review of Diabetic Gastroparesis found that the class of drugs known as glucagon-like peptide 1 (GLP-1) receptor agonists such as dulaglutide (Trulicity) may exacerbate the symptoms of diabetic gastroparesis and therefore are not recommended for individuals experiencing symptoms of gastroparesis